Siegman M J, Butler T M, Mooers S U
Department of Physiology, Jefferson Medical College, Philadelphia, PA 19107.
Biochem Biophys Res Commun. 1989 Jun 15;161(2):838-42. doi: 10.1016/0006-291x(89)92676-4.
The phosphatase inhibitor, okadaic acid, has been used to test the hypothesis that myosin light chain phosphatase activity plays a central role in latchbridge formation in smooth muscle. In the permeabilized rabbit portal vein there is a non-linear relationship between myosin light chain phosphorylation and force production such that maximum force output occurs with about 50% phosphorylation. Treatment of the muscle with okadaic acid does not change this relationship even though there is a profound inhibition of phosphatase activity. The data suggest that dephosphorylation of the myosin light chain while the myosin is in the force producing state does not account for the high force output with low levels of light chain phosphorylation in smooth muscle.
磷酸酶抑制剂冈田酸已被用于检验肌球蛋白轻链磷酸酶活性在平滑肌闩锁桥形成中起核心作用这一假说。在通透的兔门静脉中,肌球蛋白轻链磷酸化与力产生之间存在非线性关系,即磷酸化约50%时产生最大力输出。用冈田酸处理肌肉,尽管磷酸酶活性受到深度抑制,但这种关系并未改变。数据表明,在肌球蛋白处于产生力的状态时,肌球蛋白轻链的去磷酸化并不能解释平滑肌中低水平轻链磷酸化时的高力输出。